Atrás
IO Biotech Inc (IOBT) Ganando
Gráfico del Precio de Acciones IOBT
IOBT Ganando
IO Biotech Inc
$0.2
18.34%
$0.03
Al cierre: Mar 23, 16:00:00 GMT-4
$0.19
-4.78%
$0
Mercado Posterior: Mar 23, 20:00:00 GMT-4
Estadísticas clave
Cierre Anterior
$0.1766
Precio de apertura
$0.179
Rango del día
$0.179 - $0.2199
Rango de 52 semanas
$0.14 - $2.79
Volumen
1.7M
Volumen promedio
10.4M
Rendimiento de dividendos
--
EPS (TTM)
-1.34
Cap. de mercado
$14.3M
¿Qué es IOBT?
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The firm develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The firm is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.